Literature DB >> 11296301

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.

Y Hakak1, J R Walker, C Li, W H Wong, K L Davis, J D Buxbaum, V Haroutunian, A A Fienberg.   

Abstract

Neuropathological and brain imaging studies suggest that schizophrenia may result from neurodevelopmental defects. Cytoarchitectural studies indicate cellular abnormalities suggestive of a disruption in neuronal connectivity in schizophrenia, particularly in the dorsolateral prefrontal cortex. Yet, the molecular mechanisms underlying these findings remain unclear. To identify molecular substrates associated with schizophrenia, DNA microarray analysis was used to assay gene expression levels in postmortem dorsolateral prefrontal cortex of schizophrenic and control patients. Genes determined to have altered expression levels in schizophrenics relative to controls are involved in a number of biological processes, including synaptic plasticity, neuronal development, neurotransmission, and signal transduction. Most notable was the differential expression of myelination-related genes suggesting a disruption in oligodendrocyte function in schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11296301      PMCID: PMC31905          DOI: 10.1073/pnas.081071198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Myelination of cortical-hippocampal relays during late adolescence.

Authors:  F M Benes
Journal:  Schizophr Bull       Date:  1989       Impact factor: 9.306

Review 2.  Myelin-associated glycoprotein. Location and potential functions.

Authors:  B D Trapp
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 3.  Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin.

Authors:  M Schachner; U Bartsch
Journal:  Glia       Date:  2000-01-15       Impact factor: 7.452

Review 4.  MAL, a proteolipid in glycosphingolipid enriched domains: functional implications in myelin and beyond.

Authors:  M Frank
Journal:  Prog Neurobiol       Date:  2000-04       Impact factor: 11.685

Review 5.  Axonal pathology in myelin disorders.

Authors:  C Bjartmar; X Yin; B D Trapp
Journal:  J Neurocytol       Date:  1999 Apr-May

Review 6.  Emerging principles of altered neural circuitry in schizophrenia.

Authors:  F M Benes
Journal:  Brain Res Brain Res Rev       Date:  2000-03

7.  Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.

Authors:  K Mirnics; F A Middleton; A Marquez; D A Lewis; P Levitt
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

8.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

Review 9.  Molecular genetic studies of schizophrenia.

Authors:  M J Owen
Journal:  Brain Res Brain Res Rev       Date:  2000-03

Review 10.  Axonal control of oligodendrocyte development.

Authors:  B A Barres; M C Raff
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

View more
  410 in total

1.  Expression profiling with oligonucleotide arrays: technologies and applications for neurobiology.

Authors:  Timothy J Sendera; David Dorris; Ramesh Ramakrishnan; Allen Nguyen; Dionisios Trakas; Abhijit Mazumder
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Transcriptional analysis in the brain: trophin-induced hippocampal synaptic plasticity.

Authors:  Janet Alder; Smita Thakker-Varia; Ira B Black
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 3.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

4.  Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia.

Authors:  Matthew Roy Williams; Thomas Hampton; Ronald K B Pearce; Steven Richard Hirsch; Olaf Ansorge; Maria Thom; Michael Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06-04       Impact factor: 5.270

5.  Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.

Authors:  Jingrui Xing; Chenyao Wang; Hiroki Kimura; Yuto Takasaki; Shohko Kunimoto; Akira Yoshimi; Yukako Nakamura; Takayoshi Koide; Masahiro Banno; Itaru Kushima; Yota Uno; Takashi Okada; Branko Aleksic; Masashi Ikeda; Nakao Iwata; Norio Ozaki
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

6.  Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.

Authors:  Patrick R Hof; Vahram Haroutunian; Christina Copland; Kenneth L Davis; Joseph D Buxbaum
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 7.  Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.

Authors:  Julie Pongrac; Frank A Middleton; David A Lewis; Pat Levitt; Károly Mirnics
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

8.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

9.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

10.  Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Authors:  J D Buxbaum; L Georgieva; J J Young; C Plescia; Y Kajiwara; Y Jiang; V Moskvina; N Norton; T Peirce; H Williams; N J Craddock; L Carroll; G Corfas; K L Davis; M J Owen; S Harroch; T Sakurai; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2007-04-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.